Explore

Scientists Reverse Alzheimer's-like Disease in Mice Using CAR-T Cell Therapy

Scientists Reverse Alzheimer's-like Disease in Mice Using CAR-T Cell Therapy

Scientists have successfully reversed Alzheimer's-like disease in mouse models through the use of CAR-T cell therapy, a treatment typically associated with cancer. The research, published in PNAS, involved engineering CD4+ T cells to target and destroy fibrillar amyloid-beta, the toxic protein responsible for plaques in Alzheimer's brains. Unlike existing FDA-approved antibody therapies that offer marginal cognitive effects and carry risks like brain swelling, this CAR-T approach aims to reprogram the brain's immune system. The engineered helper T cells not only reduced brain pathology but also recruited additional immune cells into the brain, reshaping the central nervous system's immune landscape. This method focuses on calming the inflammatory response around plaques rather than solely clearing them. While promising, this is preclinical research, and human trials are still years away. The manufacturing of CAR-T cells is expensive, and the blood-brain barrier presents a unique challenge not found in bloo...

Study Reveals Distinct Health Profile for Early-Onset Alzheimer's Disease

A recent study conducted by the University of Oulu and the University of Eastern Finland has identified that individuals diagnosed with Alzheimer's disease before the age of 65 exhibit a unique set of health problems in the years leading up to their diagnosis. Unlike late-onset Alzheimer's, which is often linked to cardiovascular risk factors, early-onset cases show no increased prevalence of high blood pressure or hyperlipidemia. Instead, researchers observed a rise in conditions such as depression, dizziness, headaches, traumatic brain injuries, epilepsy, cerebrovascular disorders, thyroid diseases, and issues related to heavy alcohol use, particularly in the five years preceding diagnosis. Tinnitus and hearing loss were also found to be more common six to ten years before diagnosis. The study, published in the journal Alzheimer's & Dementia, analyzed data from 407 individuals with early-onset Alzheimer's and over 4,000 age- and sex-matched controls, drawing from memory clinics at Oulu University Hospita...

NewAmsterdam Pharma Initiates Phase 2b Clinical Trial for Alzheimer's Drug Targeting Biomarker Reduction

NewAmsterdam Pharma Initiates Phase 2b Clinical Trial for Alzheimer's Drug Targeting Biomarker Reduction

NewAmsterdam Pharma has enrolled the first participant in its Phase 2b clinical trial for an Alzheimer's drug. The trial aims to assess whether a year of treatment can lower Alzheimer's biomarkers in individuals who exhibit disease hallmarks but are currently asymptomatic. The company is developing obicetrapib, a cholesteryl ester transfer protein (CETP) inhibitor, which functions by preventing cholesterol from being shuttled into low-density lipoprotein (LDL). Previous Phase 3 trials of obicetrapib, conducted in individuals with heart disease or genetic high cholesterol, showed an effect on Alzheimer's blood biomarkers. Specifically, in a subgroup of 1,727 participants carrying the ApoE4 Alzheimer's risk gene, the drug lowered blood levels of pTau-217, a biomarker used in diagnosing Alzheimer's in cognitively impaired individuals. While the full implications of this biomarker reduction are still being investigated, experts suggest it indicates the drug's ability to reach the brain and alter its physiology...

Walk to End Alzheimer's Event Gathers Support in Grand Island for Research and Medicare Coverage

Walk to End Alzheimer's Event Gathers Support in Grand Island for Research and Medicare Coverage

The Grand Island Walk to End Alzheimer's took place at Amur Plaza, drawing hundreds of participants to raise awareness and funds for Alzheimer's care, support, and research. The event, organized by the Alzheimer's Association, is part of a nationwide initiative held in over 600 communities, including seven in Nebraska. Registration for the half-mile walk was free, and fundraising efforts will continue through December. The money collected supports local programs such as support groups and a helpline, as well as advocacy for Alzheimer's research at state and federal levels. A key advocacy point is pushing for Medicare coverage of biomarker blood testing, which uses a blood sample to detect amyloid and tau proteins linked to Alzheimer's, facilitating earlier diagnosis. Carla Thielbar, development director for the Alzheimer's Association, highlighted that over 35,100 Nebraskans are living with Alzheimer's, with more than 42,000 family members and friends serving as caregivers. The event included a Promise Gar...

AI Clinical Trial Design Market Projected to Reach $12.97 Billion by 2033

AI Clinical Trial Design Market Projected to Reach $12.97 Billion by 2033

AI Clinical Trial Design Market Projected to Reach $12.97 Billion by 2033

Eggs Recognized for Essential Nutrients and Health Benefits

Eggs Recognized for Essential Nutrients and Health Benefits

Eggs are being highlighted for their significant nutritional value, containing 13 essential nutrients crucial for various bodily functions. These nutrients include choline, vitamin B12, and iron, which are vital for brain development, growth, and overall brain function. Beyond these, eggs provide high-quality protein, lipids, vitamins, minerals, and various bioactive compounds. The protein found in eggs is considered complete, as it contains all nine essential amino acids, including leucine, which plays a key role in activating muscle protein pathways. For instance, 50 grams of protein can be obtained from 615 calories of boiled whole eggs or a more calorie-efficient 236 calories from boiled egg whites. This nutritional profile underscores eggs' role in supporting health across all life stages, from early childhood development to maintaining muscle mass and bone strength in older age.

Natalie Morales Joins Flow Space Women’s Health Summit in L.A.

Natalie Morales Joins Flow Space Women’s Health Summit in L.A.

Natalie Morales, award-winning journalist and TV personality, is joining the lineup of SHE Media’s Flow Space Women’s Health Summit this week. The Flow Space Women’s Health Summit will be held Thursday, Oct. 15, at Penske Media Corp.’s Los Angeles headquarters. (Disclosure: PMC is the owner of Variety.) Morales, who has spoken publicly about her family’s […]

Regular Skin Checks and Sun Protection Emphasized for Skin Cancer Prevention

Regular Skin Checks and Sun Protection Emphasized for Skin Cancer Prevention

Regular skin checks, combined with consistent sun protection and awareness of changes to one's own skin, are crucial for identifying suspicious lesions early. Australia, for instance, has one of the highest rates of skin cancer globally, including melanoma, basal cell carcinoma (BCC), and squamous cell carcinoma (SCC). While skin checks do not prevent cancer, they aid in early detection, which often leads to more straightforward treatment. Individuals with fair skin, a history of significant sun exposure, numerous or unusual moles, a personal or family history of melanoma, or a history of tanning bed use are at increased risk. General practitioners assess individual risk and advise on the frequency of examinations, which may involve inspecting various body areas and using a dermatoscope for detailed lesion examination.

Menopause Market Sees Commercialization Outpace Evidence-Based Care in the U.S.

Menopause Market Sees Commercialization Outpace Evidence-Based Care in the U.S.

The U.S. menopause market is experiencing a significant surge in commercialization, with product-led marketing increasingly outpacing evidence-based medical guidance. A JAMA Network Open study, analyzing two decades of Google Trends data, revealed that commercial searches for menopause-related products rose from one in five in 2010 to one in three by 2025. The study, led by Dr. Francesca Farina of the University of Chicago, found that 'black cohosh,' a supplement with weak evidence for treating hot flashes, was the most-searched commercial term. This trend indicates a growing gap between consumer interest in commercial solutions and the scientific evidence supporting their efficacy. Physicians and medical organizations, including the American College of Obstetricians and Gynecologists (ACOG), have expressed concerns about the rise of direct-to-consumer menopause services and the potential for commercial bias in the information women receive. The ACOG has even published a consumer guide to help women identi...

Vitalize Secures $31 Million Series A Funding to Advance AI Operating System for Hospital Staffing

Vitalize Secures $31 Million Series A Funding to Advance AI Operating System for Hospital Staffing

Healthcare AI startup Vitalize has successfully raised $31 million in Series A funding, led by Oak HC/FT. This investment aims to expand its platform, which automates hospital staffing, scheduling, and capacity management. The company's system, described as an 'air traffic control' for hospital operations, seeks to replace traditional, often inefficient methods like spreadsheets and phone calls. Vitalize's platform integrates with electronic medical record and time-and-payroll systems, utilizing machine learning, optimization models, and AI agents to forecast staffing needs, fill schedule gaps, automate workflows, and recommend patient placement decisions. The company currently works with over 15 health systems, including MemorialCare, LifeBridge Health, and Northwestern Medicine, managing millions of shifts weekly. Co-founders Veeraj Shah, CEO, and Sanketh Andhavarapu, chief product officer, developed the platform after observing the operational challenges within health systems.

WashU Medicine Researchers Identify Immune Cell Ratio Predicting Chronic Disease and Mortality

WashU Medicine Researchers Identify Immune Cell Ratio Predicting Chronic Disease and Mortality

Researchers at Washington University School of Medicine in St. Louis, in collaboration with Nationwide Children's Hospital and King's College London, have developed a map of human immune aging that identifies a ratio between two types of immune cells as a predictor of future health risks. The study, published in Immunity, analyzed approximately 12.4 million individual immune cells from 2,609 healthy adults aged 20 to over 90 across various cohorts. They found that a higher proportion of granzyme B-producing white blood cells compared to granzyme K-producing cells in healthy individuals was associated with an increased risk of death and chronic conditions such as Type 2 diabetes, hypertension, liver disease, and renal failure a decade later. Conversely, a healthy immune system tends to shift towards granzyme K cells over time. This suggests that individuals can have different immune aging trajectories, explaining varying health outcomes among people of the same chronological age.

Nighttime Light Exposure Linked to Early Heart Problem Indicators in New Study

Nighttime Light Exposure Linked to Early Heart Problem Indicators in New Study

A new study published in the European Heart Journal has identified a link between nighttime light exposure and an increased risk of developing factors associated with heart disease. Researchers analyzed data from 11,071 participants in the UK Biobank, who wore light sensors for seven days to measure nighttime light exposure. After three years, cardiac MRI scans revealed that individuals exposed to at least three lux of nighttime light (comparable to bright moonlight or light seeping under a door) exhibited thickening in the wall of the heart's left ventricle and reduced flexibility in the heart muscle during each heartbeat. These findings suggest that even low levels of light at night could be an early indicator of inefficient heart function. Dr. Yu-Ming Ni, a cardiologist, explains that this interference with the body's circadian rhythm can disrupt sleep, blood pressure, and metabolism, potentially contributing to cardiovascular risk factors like high blood pressure, obesity, and diabetes over time. Dr. C...